Lipopolysaccharide-mediated regulation of interleukin-6 in cultured human detrusor smooth muscle cells;Regulation von interleukin-6 durch lipopolysaccharid-stimulation in kultivierten humanen detrusormyozyten

Urologe - Ausgabe A

Volumn 46, Issue 9, 2007, Pages 1193-1197

  Neuhaus, J ^a   Schlichting, N ^b   Oberbach, A ^b   Stolzenburg, J U ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

gp130; gp80; IL 6; Signaling; STAT3

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; STAT3 PROTEIN;

ARTICLE; BLADDER BIOPSY; CANCER PATIENT; CELL CULTURE; CYTOKINE RELEASE; DETRUSOR MUSCLE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LAMINA PROPRIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UROTHELIUM; WESTERN BLOTTING;

BIOPSY; CELL NUCLEUS; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MUCOUS MEMBRANE; MUSCLE CELLS; MUSCLE, SMOOTH; RECEPTORS, INTERLEUKIN-6; STAT3 TRANSCRIPTION FACTOR; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 34648831638     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1479-2     Document Type: Article

References (14)

1. Abdel-Mageed AB, Bajwa A, Shenassa BB et al. (2003) NF-kappaB-dependent gene expression of proinflammatory cytokines in T24 cells: possible role in interstitial cystitis. Urol Res 31: 300-305
2. Aggarwal BB, Shishodia S, Sandur SK et al. (2006) Inflammation and cancer: how hot is the link. Biochem Pharmacol 72: 1605-1621
3. Andrews B, Shariat SF, Kim JH et al. (2002) Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol 167: 1475-1481
4. Bihl MP, Heinimann K, Rudiger JJ et al. (2002) Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor. Am J Respir Cell Mol Biol 27: 48-56
5. Bouchelouche K, Alvarez S, Horn T et al. (2006) Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha. Urology 67: 214-219
6. Iankov L, Atanasova G, Praskova M et al. (2004) Bacterial lipopolysaccharide induces proliferation of IL-6-dependent plasmacytoma cells by MAPK pathway activation. Immunobiology 208: 445-454
7. Lotz M, Villiger P, Hugli T et al. (1994) Interleukin-6 and interstitial cystitis. J Urol 152: 869-873
8. Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90: 2312-2316
9. Mitsuyama K, Sata M, Rose-John S (2006) Interleukin-6 trans-signaling in inflammatory bowel disease. Cytokine Growth Factor Rev 17: 451-461
10. Nakahara H, Nishimoto N (2006) Anti-interleukin-6 receptor antibody therapy in rheumatic diseases. Endocr Metab Immune Disord Drug Targets 6: 373-381
11. Negrier S, Perol D, Menetrier-Caux C et al. (2004) Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6-from the Groupe Francais d'Immunotherapie. J Clin Oncol 22: 2371-2378
12. Nishimoto N (2007) [Clinical benefits of anti-human IL-6 receptor antibody therapy]. Clin Calcium 17: 562-568
13. Peters KM, Diokno AC, Steinert BW (1999) Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder. Urology 54: 450-453
14. Yoshio-Hoshino N, Adachi Y, Aoki C et al. (2007) Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor. Cancer Res 67: 871-875